Tumor angiogenesis revisited: Regulators and clinical implications.
about
Effects of FSTL1 on the proliferation and motility of breast cancer cells and vascular endothelial cells.Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis.Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Tumor angiogenesis revisited: Regulators and clinical implications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Tumor angiogenesis revisited: Regulators and clinical implications.
@en
Tumor angiogenesis revisited: Regulators and clinical implications.
@nl
type
label
Tumor angiogenesis revisited: Regulators and clinical implications.
@en
Tumor angiogenesis revisited: Regulators and clinical implications.
@nl
prefLabel
Tumor angiogenesis revisited: Regulators and clinical implications.
@en
Tumor angiogenesis revisited: Regulators and clinical implications.
@nl
P2093
P2860
P50
P356
P1476
Tumor angiogenesis revisited: Regulators and clinical implications
@en
P2093
Mohammed Benkheil
Roberto Ronca
Sandra Liekens
Sofie Struyf
Stefania Mitola
P2860
P304
P356
10.1002/MED.21452
P577
2017-06-23T00:00:00Z